← Leaderboards
Royce Mohan
University Of Kentucky
$8,216,905
Attributed
$8,216,905
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,216,905 · 9
By mechanism
R01$5,232,681 · 3
R21$2,485,976 · 5
R56$498,248 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Kentucky
Same institution · by research overlap
- Zhishan Wang$3,428,407
- Ramesh C Gupta$9,549,313
- Bernhard Hennig$8,918,317
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsInjuryProteinsProgramsPharmaceutical PreparationsCorneaMolecularIn VivoInvestigationTissuesRepairedInjuredCellsMouse ModelLeadAnalogLinkSmall MoleculeAlkaliesInflammationCorneal InjuryChemical InjuryGrantInnovation
Grant awards (28)
Corneal and Schwann cell mechanisms in vesicant injury$1,467,198
R01 · FY2025 · EY · contact PI
Targeting Corneal Schwann cells to counteract against toxin injury$249,750
R21 · FY2025 · EY · contact PI
Targeting Corneal Schwann cells to counteract against toxin injury$208,073
R21 · FY2024 · EY · contact PI
Unraveling the corneal and retinal mechanisms of chemical injury$498,248
R56 · FY2023 · EY · contact PI
Targeting Citrullination in Ocular Chemical Injury$246,000
R21 · FY2022 · EY · contact PI
Defining Corneal Schwann cells in Injury$238,620
R21 · FY2022 · EY · contact PI
Targeting Citrullination in Ocular Chemical Injury$93,090
R21 · FY2022 · EY · contact PI
Targeting Citrullination in Ocular Chemical Injury$63,699
R21 · FY2022 · EY · contact PI
Defining Corneal Schwann cells in Injury$205,000
R21 · FY2021 · EY · contact PI
Targeting Citrullination in Ocular Chemical Injury$205,000
R21 · FY2021 · EY · contact PI
PAD4 in Retinal Gliosis$239,250
R21 · FY2019 · EY · contact PI
PAD4 in Retinal Gliosis$199,375
R21 · FY2018 · EY · contact PI
PAD4 in Retinal Gliosis$197,763
R21 · FY2018 · EY · contact PI
Molecular targets of Corneal Anti-fibrosis$377,300
R01 · FY2015 · EY · contact PI
Molecular targets of Corneal Anti-fibrosis$377,300
R01 · FY2014 · EY · contact PI
Molecular targets of Corneal Anti-fibrosis$385,000
R01 · FY2013 · EY · contact PI
Molecular Targets of Corneal Antiangiogenesis$363,589
R01 · FY2011 · EY · contact PI
Molecular Targets of Corneal Antiangiogenesis$323,626
R01 · FY2010 · EY · contact PI
Novel Modular Vascular Patterning Assay for HTS$223,154
R01 · FY2010 · CA · contact PI
Molecular Targets of Corneal Antiangiogenesis$38,962
R01 · FY2010 · EY · contact PI
Molecular Targets of Corneal Antiangiogenesis$366,250
R01 · FY2009 · EY · contact PI
Novel Modular Vascular Patterning Assay for HTS$295,574
R01 · FY2009 · CA · contact PI
Molecular Targets of Corneal Anti-angiogenesis$358,925
R01 · FY2008 · EY · contact PI
Novel Modular Vascular Patterning Assay for HTS$289,553
R01 · FY2008 · CA · contact PI
Molecular Targets of Corneal Anti-angiogenesis$366,250
R01 · FY2007 · EY · contact PI
Novel High Content Vascular Patterning Assay(RMI)$51,205
R21 · FY2007 · NS · contact PI
Novel High Content Vascular Patterning Assay(RMI)$112,342
R21 · FY2006 · NS · contact PI
Novel High Content Vascular Patterning Assay(RMI)$176,809
R21 · FY2005 · NS